Laboratori Fundació Dau Pharmadox Healthcare Ltd.

The medicine is used in adults to treat type 2 diabetes when it cannot be controlled with a single antidiabetic substance (metformin or sulfonylurea derivatives), diet alone, or physical exercise.

Dosage form: tablets, film-coated

ATC: A10BH05

This medicine is used in adults to reduce the risk of a subsequent heart attack or death from cardiovascular disease (following acute coronary syndrome). It is also used to reduce the risk of blood clots in people with coronary artery disease or peripheral artery disease.

Dosage form: tablets, film-coated

ATC: B01AF01

This medicine is used in adults to prevent strokes and other blood clots (in atrial fibrillation) and to treat and prevent blood clots in the leg veins and pulmonary vessels. In children and adolescents (weighing more than 30 kg), it is also used to treat blood clots after initial injectable treatment.

Dosage form: tablets, film-coated

ATC: B01AF01

This medicine is used in adults to prevent the formation of blood clots in the veins after hip or knee replacement surgery and to treat deep vein thrombosis and pulmonary embolism, as well as to prevent their recurrence.

Dosage form: tablets, film-coated

ATC: B01AF01

This medicine is used in adults to prevent strokes and other blood clots (e.g., in atrial fibrillation) and to treat and prevent blood clots in the leg veins and pulmonary vessels. In children and adolescents (weighing more than 30 kg), it is used to treat blood clots after initial injectable treatment.

Dosage form: tablets, film-coated

ATC: B01AF01

The medicinal product is used in the treatment of HIV infection and chronic hepatitis B (HBV). It may be used in adults and adolescents (from 12 to less than 18 years of age) of appropriate body weight.

Dosage form: tablets, film-coated

ATC: J05AF07